Prism Medico and Pharmacy Ltd (NSE: PRISMMEDI), ISIN INE730E01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PRISMMEDI last traded at ₹28.41 (+0.50%), with a 52-week range of ₹12.49 to ₹34.49 (as of 29 Jul 2026).
Shareholding as of Dec 2025: promoters 25.00%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 31/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.